According to the latest report by IMARC Group, titled “Digital Diabetes Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, the global digital diabetes management market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 21% during 2021-2026.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Report Sample: https://www.imarcgroup.com/digital-diabetes-management-market/requestsample
Digital diabetes management systems are a range of electronic medical solutions that simplify the management of diabetes by patients, medical professionals and caregivers. They involve mobile software, Big Data cloud computing infrastructure, and diabetes monitoring hardware. A digital diabetes management system generally offers a smart glucose monitor, mobile application, decision support system, and digital diabetes clinic. These solutions also help to manage blood pressure (BP), track and maintain patient records, and sustain cholesterol levels.
The rising prevalence of diabetes has led to an increase in the advent of highly flexible diabetes care solutions, which is majorly driving the global digital diabetes management market growth. In addition to this, the widespread adoption of connected devices and cloud-based enterprise solutions is further fueling the market growth. This is also supported by the inflating sales of smart devices across the globe. Moreover, increasing health consciousness amongst consumers has escalated the demand for blood glucose monitoring devices, which is creating a positive outlook for the market.
Digital Diabetes Management Market 2021-2026 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global digital diabetes management market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Abbott Laboratories
- ACON Laboratories Inc
- Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
- Becton, Dickinson and Company
- Dexcom Inc.
- Hoffmann-La Roche AG
- Medtronic plc
- Novo Nordisk A/S
- Tandem Diabetes Care Inc.
- Terumo Corporation
Key Market Segmentation:
The report has segmented the global digital diabetes management market on the basis of product type, device type and region.
Breakup by Product Type:
- Smart Glucose Meter
- Smart Insulin Pumps
- Smart Insulin Pens
Breakup by Device Type:
- Handheld Devices
- Wearable Devices
Breakup by Region:
- North America
- Latin America
- Middle East and Africa
Explore Full Report with TOC & List of Figure: https://bit.ly/3oD5FyO
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021-2026)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Email: [email protected]
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800